81
China Regenerative Medicine International Limited
8158.HK · HKSE
$0.31 +0.00% (+$0.00)
1M +63.16%
Market Cap $92.8M
P/E Ratio 3.37x
Div. Yield -
ROE 57.12%
Bulios Fair Price
$0.37
19.4% upside
Current Price
$0.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 8158.HK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
73 /100
Cheap P/FCF 23.05x
P/S 1.29x
P/B 2.16x
Growth
87 /100
Growing Rev. growth 20.16%
Book val. growth 25.49%
EPS growth 78.17%
Profitability
52 /100
Moderate Net margin 38.20%
Op. margin 2.21%
FCF margin 5.59%
Quality
51 /100
Average ROE 57.12%
ROA 17.47%
Asset turnover 0.46x
Debt
24 /100
High Current ratio 1.00x
Int. coverage -1.32x
Net debt/EBITDA 4.78x
Stability
18 /100
Unstable Rev. volatility 44.07%
EPS volatility 1,478.49%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 8158.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chuang Wang
Employees
33
Headquarters
Hong Kong